title: Anakinra in mutation-negative NOMID/CINCA syndrome: comment on the articles by Hawkins et al and Hoffman and Patel.
authors.forename: Joost
authors.initials: J
authors.lastname: Frenkel
authors.forename: Nico M
authors.initials: NM
authors.lastname: Wulffraat
authors.forename: Wietse
authors.initials: W
authors.lastname: Kuis
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy* / Q000235:genetics; D002352:Carrier Proteins / Q000235:genetics*; D003872:Dermatitis / Q000188:drug therapy* / Q000235:genetics; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D053590:Interleukin 1 Receptor Antagonist Protein; D008297:Male; D009154:Mutation; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; D009443:Neuritis / Q000188:drug therapy* / Q000235:genetics; D012795:Sialoglycoproteins / Q000627:therapeutic use*; D013577:Syndrome
chemical_list: D018501:Antirheumatic Agents; D002352:Carrier Proteins; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; C453881:NLRP3 protein, human; D012795:Sialoglycoproteins